Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress

Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/6182

Full metadata record

DC Field	Value	Language
dc.contributor.author	Wallington-Gates, Craig	en
dc.contributor.author	Bennett, MK	en
dc.contributor.author	Vandyke, K	en
dc.contributor.author	Davies, L	en
dc.contributor.author	Zebol, JR	en
dc.contributor.author	Moretti, PA	en
dc.contributor.author	Hewett, DR	en
dc.contributor.author	Zannettino, AC	en
dc.contributor.author	Pitson, SM	en
dc.date.accessioned	2024-08-08T03:18:09Z	-
dc.date.available	2024-08-08T03:18:09Z	-
dc.date.issued	2017	-
dc.identifier.citation	Oncotarget, 2017	en
dc.identifier.uri	https://dora.health.qld.gov.au/qldresearchjspui/handle/1/6182	-
dc.language.iso	en	en
dc.title	Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress	en
dc.type	Article	en
dc.identifier.doi	10.18632/oncotarget.17115	-
dc.rights.holder	Craig Wallington-Gates	en
dc.identifier.journaltitle	Oncotarget	-
dc.identifier.external	54687154	-
item.fulltext	No Fulltext	-
item.grantfulltext	none	-
item.openairecristype	http://purl.org/coar/resource_type/c_18cf	-
item.cerifentitytype	Publications	-
item.languageiso639-1	en	-
item.openairetype	Article	-
Appears in Sites:	Sunshine Coast HHS Publications

78

checked on Dec 21, 2024

Check